Table 5 Normalized growth rate reduction of SNU-228 and SNU-267 cells at the highest concentrations used of the indicated anti-cancer drugs

SNU-228

Control

1.13

1.37

1.24

1.34

1.43

1.45

Resistant cells

0.93 (0.82)

1.02 (0.74)

1.06 (0.85)

1.18 (0.88)

1.23 (0.86)

1.23 (0.85)

Reversible

0.94 (0.83)

1.06 (0.77)

0.93 (0.75)

1.17 (0.87)

1.24 (0.87)

1.24 (0.86)

SNU-267

Control

1.17

1.38

1.42

1.36

1.33

1.35

Resistant cells

1.05 (0.90)

1.24 (0.90)

1.27 (0.89)

1.24 (0.91)

1.23 (0.92)

1.24 (0.92)

Reversible

1.01 (0.86)

1.22 (0.88)

1.27 (0.89)

1.23 (0.90)

1.19 (0.89)

1.23 (0.91)